Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney Disease
Condition:   Autosomal Dominant Polycystic Kidney Disease (ADPKD) Intervention:   Drug: Tolvaptan Sponsor:   Korea Otsuka Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 14, 2019 Category: Research Source Type: clinical trials

Outcome of Autosomal Dominant Polycystic Kidney Disease Patients on Peritoneal Dialysis: a National Retrospective Study Based on Two French Registries (the French Language Peritoneal Dialysis Registry and the French Renal Epidemiology and Information Network).
Condition:   Polycystic Kidney Diseases Intervention:   Other: Dialysis Sponsor:   CHU de Reims Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2019 Category: Research Source Type: clinical trials

Autosomal Dominant Polycystic Kidney Disease Somatic Mutation Biorepository
Condition:   Autosomal Dominant Polycystic Kidney Disease Intervention:   Sponsors:   Weill Medical College of Cornell University;   The Rogosin Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2019 Category: Research Source Type: clinical trials

Reata Announces Clinical Trial Design for FALCON, a Phase 3 Trial of Bardoxolone Methyl for the Treatment of Autosomal Dominant Polycystic Kidney Disease
IRVING, Texas, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced that it has completed a successful end-of-Phase 2 meeting with the United States Food and Drug... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 5, 2019 Category: Pharmaceuticals Source Type: clinical trials

Metformin vs Tolvaptan for Treatment of Autosomal Dominant Polycystic Kidney Disease
Condition:   ADPKD Interventions:   Drug: Metformin;   Drug: Tolvaptan Sponsor:   Azienda Ospedaliero-Universitaria Consorziale Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2018 Category: Research Source Type: clinical trials

Lixivaptan in a Single Subject With Intractable Pain Due to Polycystic Kidney Disease
Condition:   Polycystic Kidney Intervention:   Drug: Lixivaptan Sponsor:   Palladio Biosciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2018 Category: Research Source Type: clinical trials